The rising interest in GLP-1 medications for metabolic conditions has generated a debate about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in https://oisicmfc218004.ttblogs.com/20883432/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-individuals